Neurology

Article	Citations
Association Between COVID-19 Vaccination and Rhabdomyolysis in Adults: A Vaccine Adverse Event Reporting System (VAERS) Study (S18.006)	683
Racial and Socioeconomic Disparities in Ischemic Stroke Outcomes among Non-lytic/Thrombectomy Patients (P7-5.008)	237
PRAX-562 is a Well-Tolerated, Novel Persistent Sodium Channel Blocker with Broad Anticonvulsant Activity in Multiple DEE Mouse Models (S34.007)	196
Lifestyle Contributors to Frequent Headaches in Youth	185
A Clinical Decision Rule Predicting Outcomes of Emergency Department Patients with Altered Mental Status (P5-12.003)	175
Histone Deacetylase 3 Inhibition Decreases Cerebral Edema and Protects the Blood-Brain Barrier after Stroke (S33.001)	175
The role of serum neurofilament light chain in an adult cohort of patients with acquired demyelinating syndromes of the central nervous system (P2-4.006)	175
Improved Access to Rapid Electroencephalography at a Community Hospital Reduces Inter-Hospital Transfers for Suspected Non-Convulsive Seizures (P6-8.003)	164
Perspectives From Members of an Online Community on Their Communications With Health Care Professionals About Migraine Treatment: A Social Listening Analysis (P17-2.003)	162
Experiences with a virtual nationwide seminar series for neuroimmunology trainees (P14-6.001)	137
Residual Symptoms and Long-term Outcomes after All-Cause Autoimmune Encephalitis (P5-1.002)	132
Iron accumulation correlates with disease severity in patients with Multiple System Atrophy (P15-11.002)	127
Delayed Toxic Encephalopathy Masquerading as Creutzfeldt-Jakob disease (P2-9.007)	126
Acute Neurological Inflammatory Diseases in Colombia: A Multi-center Observational Study from Zika outbreak to SARS-CoV-2 pandemic (S3.002)	123
Intravenous Immune Globulins vs Plasma Exchange Usage in Patients with Neuromuscular and Neuro-immunological Conditions (P4-13.007)	122
Cenobamate Plasma Concentrations in Patients Reaching ≥50% or 100% Responder Rates for ≥12 Months: A Post-hoc Analysis (S13.004)	120
Long-term Treatment with Galcanezumab in 29 Patients with Chronic Migraine: Results from the 3-year Continued Access Program of the REGAIN Study (P1-1.Virtual)	114
Study Design of AOC 1001-CS1, a Phase 1/2 Clinical Trial Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AOC 1001 Administered Intravenously to Adult Patients with Myoton	113
Quantitative Cerebrovascular Reactivity Atlas In Children (P14-5.003)	110
In-Hospital Glucose Measurements are Associated with Mortality after Thrombectomy for Acute Ischemic Stroke (P4-10.005)	108
Ponesimod Shows Improved Effect on Brain Volume Compared with Other DMTs, A Model Based Meta-Analysis (P1-1.Virtual)	106
Sustainability of Seizure Control With Adjunctive Cenobamate in the Phase 3 C021 Study (P12-8.001)	105
MOG Antibody-Associated Disease Manifesting as MRI-Negative Encephalitis: A Case Report and Literature Review (P16-1.004)	105
Temporal Mapping of Trigeminal Neuralgia Lesions to Symptom Onset in Multiple Sclerosis: When Do the Lesions Occur and What Do They Tell Us? (P16-4.001)	103
Proteomic profiling of sporadic late-onset nemaline myopathy (P15-13.001)	102

Determinants of Disparate Disability Accumulation in Black, Hispanic, and White Patients With Multiple Sclerosis (P1-1.Virtual)	100
Long-term survival and cognitive function follow up of primary CNS lymphoma treated with R-MVP followed by high dose chemotherapy with autologous stem cell transplant consolidation (S27.008)	99
Open-ended, value-based decision making requires semantic memory: a computational, imaging, and clinical study (P1-6.005)	97
Neuroradiological profile of Rhinoorbitocerebral mucormycosis in COVID-19 pandemic. (S18.007)	97
The Bulbar Imposter: A Case Presentation of Foix-Chavany-Marie Syndrome (P10-10.001)	96
Psychometric Evaluation of the Idiopathic Hypersomnia Severity Scale (P1-7.001)	96
Pathogenic Th17 Cells in Autoimmune Myasthenia Gravis Exhibit a Pro-inflammatory Transcriptomic Signature that Promotes Disease Pathogenesis (S41.008)	95
Accurate Test of Limb Isometric Strength (ATLIS) as an Outcome Measure in ALS and as a Marker of Upper Motor Neuron Involvement in Primary Lateral Sclerosis (S11.010)	92
Prevalence of Comorbidities in a National Sample of Lewy Body Dementia Caregivers (P15-3.005)	91
Serving Los Angeles County Patients with Teleneurology, A Clinical Tool Here to Stay (P18-8.007)	90
Functional Parcellation of the Cingulate Gyrus in Epilepsy Surgical Planning: Electrical stimulation, Electrocorticography, and fMRI study (P4-8.005)	87
Approach to patients with autoimmune encephalitis with no identifiable antibodies (P2-1.001)	85
Adaptive B-cell and T-cell responses to SARS-CoV-2 vaccination in patients with Multiple Sclerosis on disease modifying immunotherapy (S5.006)	85
BRAT1 Associated Leukodystrophy exacerbated by Lymphoma directed Chemotherapy (P13-9.005)	84
Diagnosis of Stroke and Prognosis of Interventions Using Imaging and Machine Learning (P1-1.Virtual)	84
Integration of Health Equity Rounds (HER) into a Neurology Residency Curriculum (P1-4.012)	81
Assessing Clinically Relevant Recovery of Visual Acuity Over Time in Patients with Leber Hereditary Optic Neuropathy Treated with Idebenone: Results from the LEROS Study (S40.001)	81
Serum Glucose Fluctuations Is an Independent Predictor of Adverse Outcomes in Patients with Acute Ischemic Stroke Undergoing Endovascular Treatment (P7-5.014)	81
Patient Use of Smartphone Videos to Capture Events in an Outpatient Epilepsy Practice (P7-1.009)	81
Evaluating an Intergenerational Art and Storytelling Program with Older Adults and Medical Students (P5-9.016)	81
Role of Pre-operative Mild Cognitive Impairment in Patients Undergoing Deep Brain Stimulation for Parkinson’s Disease: Systematic Review (P2-3.011)	80
Perceived Stress and its Association with Sleep Quality in Patients with Neuropathic Pain and Distal Symmetric Polyneuropathy (P3-11.020)	80
People with Epilepsy (PWE) and Attention Deficit Hyperactive Disorder (ADHD)/Attention Deficit Disorder (ADD) (P4-1.001)	79
Efficacy of Frexalimab on Physical and Psychological Impacts and Fatigue in Relapsing Multiple Sclerosis: Findings from MSIS-29v2 and PROMIS-Fatigue-MS-8a Assessments in a Phase 2 Trial (P10-6.001)	77
The Role of Platelet Rich Plasma in the Management of Vertebrogenic and Discogenic Pain (P5-13.004)	76
Half-and-Half Syndrome as Manifestation of Acute Ischemic Stroke (P8-10.005)	71
Measuring Synaptic Density and Dopamine Transporter Availability in Parkinson's Disease: A PET Imaging Study with 11C-UCB-J and 18F-FE-PE2I (P7-3.007)	71
Association Between a Brain Care Score and Risk of Cerebrovascular Events in American Women (S11.004)	70
A Ten-year Delayed Diagnosis of Hereditary Spastic Paraplegia Type-10: Key Clinical, Electrodiagnostic, and Genetic Findings (P11-11.004)	70
Investigation of Novel Variants in Familial Multiple Sclerosis Through Family-based Association Tests and Segregation Analyses (S17.007)	70
Spontaneous Spinal Epidural Hematoma Presented with Acute Hemiparesis: A Stroke Mimicker (P11-5.015)	69
Dual Amyloid Beta/Tau Vaccine PRX123 Surrogate Results in Robust Clearance of Amyloid Plaques in Brains of Aggressive APP/PS1 Mouse Model (P7-9.015)	68
Neuroimaging Evidence of Cortical-subcortical Network Involvement in Patients with Cortical Lateralized Periodic Discharges (P5-1.004)	68
Sex Chromosomes and Gonad-dependent Sex Differences in Auditory Function in Mice (P7-10.001)	68
Deep Phenotyping of Executive Function Deficits Using the NIH Toolbox in Duchenne Muscular Dystrophy (P1-11.014)	68
Monoaminergic Network Abnormalities Explain Fatigue in Pediatric Multiple Sclerosis (S8.008)	67
Patterns of Benzodiazepine Initiation Among Older Acute Ischemic Stroke Survivors (P1-10.006)	67
Temporal Trends in Quality of Acute Stroke and Secondary Stroke Prevention Care in Patients with Pre-stroke Disability in the Safe Implementation of Treatment in Stroke (SITS) Registry (P1-5.002)	66
Irrigation Versus No Irrigation in the Treatment of Chronic Subdural Hematoma: An Updated Systematic Review and Meta-analysis of 1581 Patients (P7-11.019)	66
Predicting Outcomes and Prognosis in Adult Myelopathies in Adult Non-traumatic Myelopathies (P11-14.003)	66
Structural Connectivity Changes in Brain Network After Spinal Cord Injury (P10-4.001)	64
Preclinical Development of a T Cell Receptor-engineered Regulatory T Cell Therapy for Progressive MS (S17.004)	64
The Clinical Spectrum of Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease: A Single Center Experience (P9-14.018)	64
Methylation Patterns Differ Between ICH Cases and Controls (S34.002)	63
Prospective Long-term Seizure Outcomes in Medically-resistant Focal Epilepsy Subjects with Neuromodulation Devices (P3-1.009)	63
Association of Cytokine Proteins with Disease Activity in Neuromyelitis Optica Spectrum Disorder Participants Receiving Inebilizumab Treatment (S32.005)	62
Community-driven Brain Health Workshop Series: A Novel Approach to Brain Health Promotion in Rochester’s Historically Marginalized Communities (P1-4.007)	62
Cervical Motion Alterations and Brain Functional Connectivity in Cervical Dystonia (P1-3.014)	62
Reconsidering the Ethics of Provocation Techniques for Psychogenic Non-epileptic Seizures and Proposed Ethical Guidelines for Use (P2-10.005)	62
Designing Transgene Vectors for ALS Therapeutics (P11-4.010)	62

Pathogenic MUYTH and Novel H3F3A Variants in Glioblastoma: A Case Report and Literature Review (P4-5.005)	62
Therapeutic Efficacy of Repetitive Nerve Stimulation (RNS) Therapy in Functional Movement Disorders: A Quantitative and Qualitative Analysis (N6.003)	61
Unraveling Complexity: Concurrent Myxopapillary Ependymoma and Pancreatic Gastrinoma in a Young Adult - A Syndromic Association or Mere Coincidence? (P6-5.010)	60
Analysis of the Epidemiologic Profile, Prevalence, and Incidence of Migraine out of 15,490 Spontaneous Intracranial Hypotension Patients from a Multicenter Record Database (TriNetX) (P2-12.008)	60
Geographic Distribution of Amyotrophic Lateral Sclerosis (ALS) in the Chicagoland Area (P6-11.015)	60
Serum Neuroinflammatory Biomarkers and Long-term Cognitive Dysfunction (P11-13.002)	60
Use of a Trial Innovation Network (TIN) Recruitment Innovation Center (RIC) Survey to Improve Subject Recruitment and Enrollment in an Adolescent Concussion Study: CARE4Kids (P2-14.004)	59
Reduced Aβ Amyloid Deposits Relate to Inflammation and Neuronal Survival in Multiple Sclerosis Cortex (S17.003)	59
Machine-learning Assisted Swallowing Assessment: A Deep Learning-based Quality Improvement Tool to Screen for Post-stroke Dysphagia (S6.004)	59
Bariatric Surgery as a Potential Trigger for Worsening HSP (P2-11.020)	59
Impact of Psychiatric Conditions on the Real-world Effectiveness of Eptinezumab Treatment in Patients with Chronic Migraine (P4-12.005)	58
VGL101: An Immunotherapy that Enhances Microglial Survival for Adult-onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP) (P9-9.013)	57
Burkitt Lymphoma-associated GAD65 Encephalitis in a Child with New-onset, Refractory Seizures (P1-14.007)	57
Correlation of Headache Frequency and Intensity with the Risk of Obstructive Sleep Apnea in Patients with Idiopathic Intracranial Hypertension (P10-12.007)	57
Amyotrophic Lateral Sclerosis Survival and Occupational Lead Exposure in the Danish National Patient Registry (P2-15.002)	57
A Sensor-based Data Capture Solution for Home-based Gait Assessment: The GAIT-HUB System (P6-6.004)	56
Analyzing White Matter Integrity of the Basolateral Amygdala and Subgenual Anterior Cingulate Cortex and Its Association with Depression in Adults with Autism Spectrum Disorder Using the Shannon Entro	56
Anti-NMDA Encephalitis Co-positive with Aquaporin 4 Antibodies in a 4-year-old Female (P6-8.004)	56
The Path to Finding a Unifying Diagnosis – A Case Report of Mitchell Syndrome in a Pediatric Patient (P2-8.005)	56
Mexiletine for the Treatment of Refractory Chronic Migraine: A Retrospective Chart Review (P6-12.005)	56
Optimal Care Access Disparities in Adult Non-English-speaking Patients with Drug-resistant Epilepsy (P10-1.005)	56
A Preliminary Systematic Review and Meta-analysis of Randomized Control Trials of Rimegepant and Zavegepant for Acute Pain Relief from Migraine (P9-12.004)	55
Determining the Impact of Longitudinal Simulation-based Learning and Evaluation on Neurology Trainee Knowledge and Confidence: A Pilot Project (P8-7.005)	54
Ataluren Delays Clinically Meaningful Milestones of Decline in 6WMD in Patients with nmDMD from Study 041, a Phase 3, Placebo-controlled Trial (S21.001)	53
Machine Learning-enhanced Dementia Testing: Reliability and Accuracy of the Autonomous Cognitive Examination (S1.008)	53
Chronic Kidney Disease and Risk of Intracerebral Hemorrhage: The Role of Hypertension as a Mediator (S34.004)	52
Clinical and Autonomic Features Suggest Phenoconversion from Sporadic Adult-onset Ataxia to Clinically Probable Multiple System Atrophy (P6-3.019)	52
Implementing and Assessing a Neuropalliative Communication Curriculum for Neurology Resident Physicians (P6-7.003)	51
What’s that Mass? A Sphenoid Lesion Causing Cavernous Sinus Syndrome (P3-14.009)	51
Clonidine Withdrawal Resulting in Atypical Presentation of PRES (P2-8.007)	51
A Comparison of Subperiosteal or Subgaleal Drainage with Subdural Drainage on The Outcome of Chronic Subdural Hematoma Surgery (P7-11.012)	50
Development of eIF2B Activator ABBV-CLS-7262 as a Novel Treatment for Vanishing White Matter Disease (P2-8.001)	50
Three Month Functional Outcomes in Poor Grade Subarachnoid Hemorrhage Patients Undergoing Endovascular Treatment of Cerebral Vasospasm (P7-5.032)	50
Exposure-Response Modeling to Describe Change in Brain Amyloid Following Lecanemab Administration in Patients with Early Alzheimer’s Disease (P9-9.011)	50
Acute Spinal Cord Infarction Following Cannabis Exposure (P7-5.015)	50
7T MRI Leptomeningeal Enhancement and Brain Atrophy Are Associated with Alterations in Arginine-polyamine Metabolism in Multiple Sclerosis (P11-6.007)	49
Oral health-related quality of life in multiple sclerosis and neuromyelitis optica spectrum disorder patients from Argentina (P5-3.007)	49
Teaching NeuroImage: Wallerian Degeneration of the Corticospinal Tract After Cerebral Hemorrhage	49
Jugular Variant Bow-Hunter’s Syndrome from Sternocleidomastoid Entrapment of the Internal Jugular Vein (P11-10.001)	49
Relationships among Hospital Acute Ischemic Stroke Volumes, Hospital Characteristics, and Outcomes in the US (P14-5.025)	49
Neuropsychologic Impact of MOGAD: A Patient Reported Outcomes Study	48
Measles, Rubella, and Varicella-Zoster Viral Antibodies and Clinical Prognosis After 20 Years in Persons with Multiple Sclerosis	48
Modifiable Vascular Risk Factors and Subsequent Brain Metrics in Hispanic/Latino Populations	48
Comparative Efficacy of Adjuvant Rifampicin, Levofloxacin, and Their Combination in Tuberculous Meningitis With and Without HIV Co-infection: A Systematic Review and Meta-Analysis	48
Teaching NeuroImage: Foramen Magnum Dural Arteriovenous Fistula Presenting With Thoracolumbar Myelopathy	48
Incidence of Relapses After Meningococcal Vaccination in Clinical Trials of Eculizumab and Ravulizumab in Anti-Aquaporin-4 Antibody-Positive (AQP4-Ab+) Neuromyelitis Optica Spectrum Disorder (NMOSD)	48
[ 11 C]PK11195-PET Brain Imaging of the Mitochondrial Translocator Protein in Mitochondrial Disease	48
Pearls & Oy-sters: Vocal Cord Palsy as the Presenting Manifestation of Neurosarcoidosis	47
Characterizing Double-Negative Neuromyelitis Optica Spectrum Disorder: A Systematic Review and Meta-Analysis	47
Characterization of Clinical Course, Diagnosis, Treatment, and Outcomes of Intravascular Lymphoma with Neurologic Involvement	47
The Use of APE2 Score to Diagnose Autoimmune Encephalitis	47
Author Response: Pediatric and Adult Brain Death/Death by Neurologic Criteria Consensus Guideline: Report of the AAN Guidelines Subcommittee, AAP, CNS, and SCCM	47
Paws for Relief	47
2024 Annual Highlights of the Resident & Fellow Section: A Representative Collection of Previously Published Articles	46
Message From the Editors to Our Reviewers	46
Teaching NeuroImage: Ventricular Garlands in Late-Onset Alexander Disease	46
Assessing the Impact of Immune Checkpoint Inhibitor Therapy on Disease Activity in Multiple Sclerosis Patients	46
Adding the Optic Nerve in Multiple Sclerosis Diagnostic Criteria	45
Airborne Trichloroethylene Exposure and Parkinson’s Disease Risk in Medicare Beneficiaries (S2.001)	45
What Is the Role of Norepinephrine in Cerebellar Modulation and Stress-Induced Episodic Ataxia?	45
Functional Eloquence Weighted Imaging	44
Association of the Cervical Canal Area With Disability and Progression in People With Multiple Sclerosis	44
Changes in Myasthenia Gravis Incidence in Denmark From 1985 to 2021	44
Editors' Note: Association of Time of Day When Endovascular Therapy for Stroke Starts and Functional Outcome	44
Glucocerebrosidase Deficiency Mediates Propagation of Protein Aggregation in Neurodegeneration via Modification of Extracellular Vesicles (S36.006)	43
Risk and Predictors of Relapse after Smoking Cessation in Patients with Ischemic Stroke and Transient Ischemic Attack (P1-1.Virtual)	43
A Clinical Bulbar Assessment Scale for ALS/MND: Preliminary Validation (S11.007)	43
Variants in PNPLA8 are Associated with Developmental Epileptic Encephalopathy and Cerebellar Atrophy. (P6-5.002)	43
Impact of Multiple Sclerosis Disease-Modifying Therapies on Effectiveness of SARS-Cov-2 Vaccines: A Longitudinal Total Population Study of National Health Service (NHS) England (S5.008)	43
Comment: Introducing Neuromodulation in 2035	43
A Case of Contrast-Induced Encephalopathy in The Setting of Acute Stroke Thrombolysis (P1-1.Virtual)	42
Teaching Neuro Images : CNS actinomycosis in an immunocompetent patient	42
Lest We Forget: Ammonia in Encephalopathic Cancer Patients (P1-1.Virtual)	42
Completing the NIHSS Score Prior to CT Scan to Reduce Time to Acute Intervention for Stroke: A Quality Improvement Project (P17-10.008)	42
Artificial intelligence identifies spectral biomarkers for use in adaptive deep brain stimulation in Parkinson’s disease (S16.004)	42
Identification of early ischemia on non-contrast CT head using artificial intelligence (S6.007)	42
Clinical evidence that treatment with pepinemab, a novel regulator of neuroinflammation, provides cognitive benefit to patients with Huntington’s and potentially other neurodegenerative diseases (P3-1	42
Postpartum Risk of Cerebral Venous Thrombosis (P10-10.006)	42
Glymphatic Impairment in Multiple Sclerosis: A New Pathological Mechanism Associated with Disease Burden (S5.010)	42
Early Neurological Improvement Can Reduce Intensive Care Unit Length of Stay in Aneurysmal Subarachnoid Hemorrhage (P12-10.008)	42

Distinguishing Quantitative EEG Correlates of Psychogenic Non-Epileptic Seizures versus Epilepsy (P1-1.Virtual)	41
Amyloid beta deposition and cognitive decline in Parkinson’s disease: a study of the PPMI cohort (P1-1.Virtual)	41
The Association of Posterior Reversible Encephalopathy Syndrome with COVID-19: A Systematic Review (P1-1.Virtual)	41
A Rare Case of Giant Cell Arteritis Presenting With Transient Polycranial Neuropathies (P6-12.004)	41
An IDH Wildtype, EGFR Amplified and TERT Promoter Mutated Astrocytoma that is Clinically and Molecularly Incompatible with the Diagnosis of Glioblastoma, IDH Wildtype. (P13-9.001)	41
Vision-Specific Quality of Life in Patients with Post-Acute Sequelae of COVID-19 (PASC) (P18-12.005)	41
Descriptive Analysis of Acute Ischemic Stroke in COVID-19 Patients Through The Course of COVID-19 Pandemic (P18-10.009)	41
Unmet Treatment Needs in Migraine Among Those Seeking Care from Neurologists or Headache Specialists: Results of the OVERCOME US study (P17-2.002)	41
Cardiac MRI in Duchenne and Becker Muscular Dystrophy (P14-13.001)	41
Real-World Experience of Perampanel Monotherapy in Epilepsy Patients with Focal-Onset and Generalized-Onset Seizures (P15-8.002)	40
Novel Ischemic Stroke Treatment Protocol for Salvageable Penumbra in Acute Small Vessel Disease (S6.010)	40
Reader Response: Teaching NeuroImage: Cryptococcal Meningoencephalitis With Cryptococcoma and Gelatinous Pseudocysts	40
Bilateral temporal lobe epilepsy: How many seizures are required in chronic ambulatory electrocorticography to estimate the laterality ratio? (S7.010)	40
Comparison of Pharmacokinetic Profiles and Safety Outcomes with Peginterferon Beta-1a Administration in Black/African American and White Participants (P4-4.009)	40
Teaching NeuroImage: Seizures as the Initial Symptom of Relapsing Polychondritis	40
Association Between COVID-19 Vaccination and Cerebrovascular Accidents in Adults: A Vaccine Adverse Event Reporting System (VAERS) Study (S18.002)	40
Increased Healthcare Cost and Mental Health Burden among Patients with Essential Tremor: A Retrospective Observational Study in A Large US Commercially Insured and Medicare Advantage Population (P15-1	40
Reader Response: Use of Social Media in Health Care—Opportunities, Challenges, and Ethical Considerations: A Position Statement of the American Academy of Neurology	40
123I-Ioflupane SPECT Striatal Binding Ratio Predicts Progression of Parkinsonism in a Dementia with Lewy Bodies Cohort (P11-6.004)	39
Blood Pressure Variability and Cognition in Black and White Older Adults Over 18 Years of Follow-up	39
Motor Outcomes to Validate Evaluations in Facioscapulohumeral muscular dystrophy (MOVE FSHD): Protocol for an observational study. (S29.007)	39
Metronidazole Induced Encephalopathy Responsive to High Dose Thiamine (P4-12.006)	39
My First Patient With Alzheimer's	39
Reliability of Reachable Workspace (RWS) Measurement System in a Large, Multi-Site, International FSHD Clinical Study (P13-13.002)	39
Brain Perfusion Imaging and Cardiac Thrombus Detection	39
Tuberculous Meningitis: Is the Fixed Dose Anti-TB treatment strategy effective? Case report from Sri Lanka (P3-10.002)	38
Monitoring Faciobrachial Dystonic Seizures with Wearable Devices (P5-5.015)	38
Coexistance of Probable Neurosarcoidosis and Generalized Myasthenia Gravis: Case Report	38
Brain MRI Activity During the Year Before Pregnancy Can Predict Long-Term Clinical Worsening in Patients with Multiple Sclerosis (P11-3.018)	38
Association of Disease Characteristics with Utilization of Behavioral Medicine in Patients with NMOSD and MOGAD (P13-5.016)	38
Facing the challenges of chief resident year: A standardized experiential simulation leadership curriculum (S13.002)	38
A Case of Infant-type Hemispheric Glioma with NTRK1 fusion (P9-13.003)	38
NMDA Receptor Encephalitis With Severe Orofacial Dyskinesias Treated With Tramadol and Clonazepam	38
Improving Residents’ Knowledge and Interest in Outpatient Neurology through an Interactive, Discussion-Based, Patient-Centered Didactic Series (P2-2.006)	38
Ixekizumab-associated transverse myelopathy in a patient with psoriatic arthritis (P14-3.017)	38
Mechanical Angioplasty with Comaneci for the Treatment Refractory Vasospasm Secondary to Coccidioidal Meningits (P2-7.005)	38
Glial Fibrillary Acidic Protein (GFAP) Antibody-Associated Astrocytopathy in Systemic Sarcoidosis	38
Effectiveness of Lower Rituximab Doses in Neuromyelitis Optica Spectrum Disorder: A Population-based Cohort Study (S50.006)	38
Association of Subthalamic Beta Frequency Sub-bands to Symptom Severity in Patients with Parkinson’s Disease: A Systematic Review (P5-11.014)	37
Implementation of Depression Screening and Interventions Protocol in a Pediatric Neurology Residents’ Continuity Clinic: A Quality Improvement Project (P11-9.001)	37
Pathologically- confirmed Osmotic Demyelination in the Case of Clinically and Radiographically Progressive Encephalopathy due to Liver Disease and Malnutrition. (P4-4.007)	37
Distinguishing Features of MOG Positive and MOG Negative Pediatric Patients with ADEM (S2.008)	37
The initial reduction in the percentage of peripheral lymphocytes and long disease course are associated with sustained response to Dimethyl Fumarate (DMF) in a small cohort of patients with Relapsing	37
Abnormalities of lipid metabolism in neuronal models of CoQ10 deficiency (S49.004)	37
African-Americans With Multiple Sclerosis Have a Higher Proportion of B-Cell Lineage Cells in Their Cerebrospinal Fluid (CSF) Than White Patients (P9-3.010)	37
COVID-19 Infection Presents as Acute Cerebellar Ataxia (P6-10.003)	37
Analytical and Clinical Assessment of Plasma Phospho-Tau Isoforms in Alzheimer’s Disease (AD) (S15.006)	37
Neurocognitive Manifestations of Individuals with NF1 Microdeletions (P14-9.007)	36
Investigating the Impact of Virtual Versus In-Person Small Group Discussion on Academic Performance in a First-Year Medical Neuroscience Course (S10.003)	36
Dystonia with myoclonus and vertical supranuclear gaze palsy associated with a rare GNB1 variant (P11-11.008)	36
Valproic Acid is an Effective Anti-Emetic Treatment in Alexander Disease (P10-9.010)	36
Efficacy and Safety of Anti-CGRP Monoclonal Antibodies for Migraine Preventative Treatment (P6-12.011)	36
Proximity to Green and Blue Spaces and Serious Psychological Distress in Urban-Dwelling Older Adults: Analysis of Washington State BRFSS data (P2-12.006)	36
Recognizing Neuropathic Pain as a Symptom of Charcot-Marie-Tooth Disease that impacts Quality of Life (P14-8.005)	36
Acute Anterograde Amnesia with Bilateral Hippocampal and Globus Pallidus Lesions (P4-12.007)	36
Survival and Clinical Characteristics of Patients with Glioblastoma with Primitive Neuronal Component (P13-13.004)	36
COVID-19 Outcomes in Neurosarcoidosis (P9-5.012)	36
Diffuse Leptomeningeal Glioneuronal Tumor (DLGNT) with Direct Cystic Infiltration of the Optic Chiasm and Tracts (P1-9.003)	36
Dual antiglutamatergic treatment in patients with status epilepticus: a case series (P9-1.008)	36
Evaluating Quality of Website-Derived Concussion Information (P8-1.005)	36
Global Mortality of Chronic Inflammatory Demyelinating Polyneuropathy Patients Treated with Intravenous Immunoglobulin versus Steroid Therapies (P10-5.006)	36
Aqueously diffusible RNA-bound amyloid-β aggregates in Alzheimer disease brain (P1-6.004)	36
Anti-IgLON-5 Associated Neurological Disease Presenting with Bilateral Optic Neuritis, Orthostatic Intolerance, Sleep-Related Movements in Setting of Testicular Mass: Expanding Clinical Phenotypes in	36
Safety and Efficacy of Inebilizumab in AQP4+ NMOSD Participants with History of Immunosuppression Treatment Prior to N-MOmentum Study (P13-5.003)	36
Distance Travelled by patient for appointment with the Movement disorder clinic at Kentucky Neuroscience Institute – how to solve the problem? (P10-11.005)	35
The Prevalence and Etiologies of Transverse Myelitis in Latin America: A Systematic Review (P4-8.011)	35
The Risk of Depression in a Large Huntington Disease Population Compared With Controls: Analysis of the Enroll-HD Registry Data (P1-11.012)	35
Focal Cerebral CNS Vasculitis due to SARS-CoV-2 Infection (P4-10.007)	35
Prevalence of Autoantibody Positivity and Associated Neuropathologies in the Oldest-old (P3-6.009)	35
MOG antibody-associated encephalitis in adult: clinical phenotypes and outcomes (P13-5.020)	35
Optical Coherence Tomography Angiography (OCTA) Retinal Imaging Can Detect Burden of Small Vessel Disease and Amyloid Deposition in the Brain (P11-5.001)	35
Assessing Undergraduate Neurology Pipeline Programs: A Systematic Review (P11-2.001)	35
Assessing Social Cognition Across Dementia Subtypes (P6-6.004)	35
Benign Paroxysmal Positional Vertigo: The “SemontPLUS Maneuver” is more effective than the Epley Maneuver – a Prospective Tri-national Randomized Single-Blinded Trial in 195 Patients (S12.003)	35
The relationship between gender, peer victimization, mental health, and frequent headaches in adolescents: A Canadian population-based observational study (P14-12.002)	34
Synergistic effect of MTHFR polymorphisms in arterial ischemic stroke in young adult (P3-5.014)	34
Risk Factors and Outcome of Cerebrovascular Complications in Transplant Recipients (P14-5.013)	34
4 mA tDCS improves walking ability in PSP: A case study (P9-11.012)	34
Author Response: D313Y Variant in Fabry Disease: A Systematic Review and Meta-analysis	34
Examining Age-Specific Barriers and Facilitators to Research Participation in Underrepresented Americans (P14-6.003)	34
Evaluation of the Clinical Outcomes and Disease Burden in Advanced Parkinson’s Disease Patients: PROSPECT Study Preliminary Results (P10-11.009)	34
Data-Driven Genome-Wide Association Study of Pain Trajectories in Persons with Parkinson’s Disease (P7-11.012)	34
The Quix Test: Identifying Vestibular Dysfunction in the “Dizzy Patient” (P7-4.004)	34
Identification of the cuproptosis-related gene signature associated with the tumor environment and prognosis of patients with glioblastoma multiforme (GBM) (S17.003)	34
Classifying Papilledema Using Machine Learning – Modernizing Frisén Grading (S12.001)	34
MOG Antibody-Associated Bilateral Optic Neuritis Associated with Johnson and Johnson COVID-19 Vaccination (P12-3.009)	33
Chemotherapy-Related Cognitive Impairment and Changes in Neural Network Dynamics	33
Author Response: Automated Quantitative Pupillometry in the Critically Ill: A Systematic Review of the Literature	33
Health Care Delivery and Financial Considerations in Amyotrophic Lateral Sclerosis Clinics	33
A Broader Perspective on Motor Rehabilitation Guidelines for Cerebral Palsy	33
Endovascular Therapy for NIHSS ≤5	33
Towards Machine Learning-Based Cognitive Examination (S2.010)	33
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) and Anti-N-Methyl-D-Aspartate Receptor Encephalitis (NMDARE) Overlapping Syndrome Presenting as Tics and Cognitive Symptoms (P10	32
Pregnancy-related Anticipatory Guidance for People with Epilepsy in Pediatric and Adult Neurology (P1-9.015)	32
CTA Collaterals, HIR, and Infarct Volume: Which Imaging Modality Best Predicts Clinical Outcomes in Acute Ischemic Stroke Endovascular Treatment? (S2.010)	32